Sociedad Americana de Hirudoterapia

Effect of Unloading Condition on the Healing Process and Effectiveness of Platelet Rich Plasma as a Countermeasure: Study on In Vivo and In Vitro Wound Healing Models

Preclinical published in Int J Mol Sci (2020)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Desarrollo de fármacosFarmacología salivalCialdai F et al. · International journal of molecular sciences, 2020

Abstract

Wound healing is a very complex process that allows organisms to survive injuries. It is strictly regulated by a number of biochemical and physical factors, mechanical forces included. Studying wound healing in space is interesting for two main reasons: (i) defining tools, procedures, and protocols to manage serious wounds and burns eventually occurring in future long-lasting space exploration missions, without the possibility of timely medical evacuation to Earth; (ii) understanding the role of gravity and mechanical factors in the healing process and scarring, thus contributing to unravelling the mechanisms underlying the switching between perfect regeneration and imperfect repair with scarring. In the study presented here, a new in vivo sutured wound healing model in the leech (Hirudo medicinalis) has been used to evaluate the effect of unloading conditions on the healing process and the effectiveness of platelet rich plasma (PRP) as a countermeasure. The results reveal that microgravity caused a healing delay and structural alterations in the repair tissue, which were prevented by PRP treatment. Moreover, investigating the effects of microgravity and PRP on an in vitro wound healing model, it was found that PRP is able to counteract the microgravity-induced impairment in fibroblast migration to the wound site. This could be one of the mechanisms underlying the effectiveness of PRP in preventing healing impairment in unloading conditions.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsCell CountCell MovementCollagenElasticityGene Expression RegulationLeechesMiceModels, BiologicalNIH 3T3 CellsPlatelet-Rich PlasmaVascular Endothelial Growth Factor A

Resumen

Novel sutured wound-healing model in Hirudo medicinalis demonstrates that microgravity impairs healing; platelet-rich plasma reverses microgravity-induced delays and structural alterations.

Por qué esto importa para la hirudoterapia

This study used Hirudo medicinalis as an in-vivo sutured wound healing model to evaluate the effects of unloading (microgravity) conditions on tissue repair and the effectiveness of platelet-rich plasma (PRP) as a countermeasure, supplemented by an in-vitro fibroblast migration model. It is relevant to ASH's domain only insofar as the leech serves as the experimental subject for studying wound healing biology—the study found microgravity caused healing delays and structural alterations in leech repair tissue, prevented by PRP. However, the leech here is used as a model organism, not as a therapeutic agent; the study does not investigate hirudotherapy, leech saliva, leech secretome components, or any leech-derived intervention. The focus is on wound healing mechanisms under microgravity and PRP efficacy, with no therapeutic application of leeches or leech products.

Citación

Effect of Unloading Condition on the Healing Process and Effectiveness of Platelet Rich Plasma as a Countermeasure: Study on In Vivo and In Vitro Wound Healing Models.

Cialdai F et al. · International journal of molecular sciences, 2020

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.